Skip to main content

Long-term follow-up of torpedo maculopathy: a case series and mini-review

Abstract

Background

Torpedo maculopathy (TM) is a rare, congenital condition characterized by an oval-shaped, chorioretinal lesion in the temporal macula of unknown etiology. To our knowledge, the longest reported follow-up of TM is 5 years. Herein we report 10 years of follow-up on two patients with TM to further characterize the long-term natural history of the condition.

Case reports

Two patients with torpedo maculopathy were examined at baseline and then again at 5 years and 10 years from baseline. Eyes were evaluated using color fundus photography, automated perimetry, fundus autofluorescence and spectral domain optical coherence tomography. Visual function of both patients remained stable throughout the observation period. In case 1, there was no evidence of change in lesion morphology over the 10 year observation period. Case 2 showed progression of cystic degeneration of the neurosensory retina within the torpedo lesion. Case 1 reported a history of supernumerary teeth and underwent gene sequence with deletion/duplication analyses of the APC gene but no clinically significant variants were detected.

Conclusions

Our findings support the position that TM is a nonprogressive condition with long-term stability of visual function. Genetic analysis of case 1 failed to detect any association with Gardner syndrome.

Peer Review reports

Background

Torpedo maculopathy (TM) is a rare, congenital condition characterized by an oval-shaped, chorioretinal lesion in the temporal macula of unknown etiology [1]. It is believed to represent a developmental defect of the eye, but theories vary as to whether it is primarily a defect in the development of the retinal nerve fiber layer [2], retinal pigment epithelium [3] or choriocapillaris [4].

The clinical features of TM include a unilateral, solitary, hypopigmented lesion in the temporal macula having a fusiform (“torpedo”) shape with its long-axis oriented horizontally and its nasal edge pointed toward the fovea [1]. However, many variations of this typical presentation have been reported [5,6,7,8,9]. Common variants include presence of outer retinal cavitation, choroidal excavation, and hyperpigmentation within the torpedo lesion. Less common variants include bilaterality, multiplicity, and atypical fundus location. The diagnosis of torpedo maculopathy is clinical and based upon recognizing the distinctive features of the condition.

There is some question as to whether the variability in clinical features of TM represents differences in phenotype or different stages of a progressive disorder [8, 10,11,12,13]. To date, the longest published follow-up of TM is 5 years. Most reports with follow-up have found torpedo lesions to be stationary, but two case reports each with 5 years of follow-up found morphologic changes of the lesion over time [8, 11].

The purpose of this paper is to present the 10 year follow-up findings of two patients with TM. To our knowledge, this represents the longest reported follow-up of any patient with TM.

Case 1

This patient initially presented to the Rosenberg School of Optometry eye clinic in 2012. Her baseline findings have been previously reported [14]. In summary, she was a healthy 25-year-old South Asian female who was discovered to have a torpedo lesion in her left eye during routine examination. Her best corrected visual acuity was 20/15 in each eye. The fundus of each eye was normal with the exception of a torpedo-shaped, excavated lesion temporal to the fovea in the right eye (Fig. 1A). Fundus autofluorescence revealed patchy regions of hyper-autofluorescence along the margins of the lesion. The temporal half of the lesion was densely hypo-autofluorescent with patchy regions of hypo-autofluorescence within the nasal portion of the lesion (Fig. 1B). Optical coherence tomography (OCT) revealed that the temporal aspect of the lesion was steeply excavated with severe disorganization of the outer retinal layers and loss of inner choroidal layers (Fig. 1C). The lesion became less excavated nasally with gradual recovery of normal retinal and choroidal structure at its nasal margin. Standard automated perimetry using the 30 − 2 test pattern was normal for both eyes, but a scotoma corresponding to the temporal half of the lesion could be demonstrated using microperimetry (Fig. 1D-E).

Fig. 1
figure 1

Case 1. A Color fundus photography demonstrates a horizontally oval, hypopigmented, torpedo-shaped lesion in the temporal macula. Serial photography documents apparent stability of the torpedo lesion over the 10 year observation period. Fundus autofluorescence demonstrates typical features of TM, including hypoautoflurescence of the lesion interior and hyperautofluorescence of the lesion margins. There is no apparent change in the signal pattern over the observation period. C Spectral domain optical coherence tomography (OCT). Each image represents a horizontal B-scan through approximately the same location in the middle of the torpedo lesion. Because the examinations were performed on different instruments at each time period, the scans are not of the identical fundus location. Nonetheless, they are as close to the same fundus location as possible. Comparison of the images suggests that the lesion has remained relatively stable over the observation period. D Microperimetry was only performed at baseline and the 5 year follow-up visit. No change in the size or depth of the scotoma produced by the deeply excavated temporal aspect of the torpedo lesion was detected. E Standard automated perimetry was normal at each visit

The patient returned for follow-up in 2017 (Fig. 1, YEAR 5) and again in 2023 (Fig. 1, YEAR 10). No changes in visual function or lesion morphology were noted at either follow-up visit. Because the patient had relocated, her 2023 exam was conducted at the SUNY College of Optometry eye clinic. At that time her ocular and medical history remained unremarkable. However, upon direct questioning the patient reported a history of supernumerary teeth. She denied a history of cranial osteomas, epidermal cysts, intestinal polyposis, or brain and other tumors. Given the possible association between TM and Gardner syndrome [15], the patient underwent gene sequence and deletion/duplication analyses of the APC gene. No clinically significant variants were detected. The patient also underwent colonoscopy with no abnormalities found. The patient’s blood relatives were not available for examination, but the patient informed us that her immediate blood relatives underwent eye examinations and no retinal lesions were uncovered. The patient was advised to self-monitor her vision with an Amsler grid.

Case 2

This patient initially presented to the Rosenberg School of Optometry eye clinic in 2012. Her baseline findings have been previously reported [14]. In summary, she was a 22 year old African American female who presented for routine eye examination. She reported that the vision of her right eye has always been worse than her left eye for unknown cause. She has a medical history of lupus erythematosus and anemia. Her medication list consisted of hydroxychloroquine, prednisone, methotrexate, metronidazole, and oral contraceptives. Her best-corrected visual acuities were 20/50 and 20/20 in the right and left eyes, respectively. The fundus of each eye was normal with the exception of a torpedo-shaped, excavated lesion involving the macula of the right eye (Fig. 2A). The bulk of the lesion was situated in the temporal macula, but its nasal edge involved the fovea, resulting in the loss of visual acuity. On fundus autofluorescence imaging the lesion was hypo-autofluorescent with a narrow ring of hyper-autofluorescence extending around the margins of the lesion except temporally, where the boundary of the lesion appears less discrete (Fig. 2B). OCT revealed steep excavation at the nasal edge of the lesion with a tapered upward sloping margin temporally (Fig. 2C-D). Standard automated perimetry using the 10 − 2 and 30 − 2 test patterns revealed a dense scotoma nasal to fixation (Fig. 2E).

Fig. 2
figure 2

Case 2. A Color fundus photography demonstrate a horizontally oval, hyperpigmented, torpedo-shaped lesion containing a central pseudolacuna in the right eye. A small satellite lesion is noted adjacent to the temporal margin of the lesion. Serial photography documents apparent stability of the lesion over the 10 year observation period. B Fundus autofluorescence demonstrates typical features of TM, including hypoautoflurescence of the lesion interior and hyperautofluorescence of the lesion margins. The lesion is interrupted near the temporal margin by a tongue of tissue with normal autofluorescence signal that splits the lesion into two parts. This corresponds to the observed satellite lesion at the temporal edge of the torpedo lesion. There is no apparent change in the signal pattern over the observation period. Scanning laser ophthalmoscopy images with location of corresponding B-scan highlighted in the baseline and 10-year follow-up exam. D Spectral domain optical coherence tomography (OCT). Each image represents a horizontal B-scan through approximately the same location in the middle of the torpedo lesion. Because the examinations were performed on different instruments at each time period, the scans are not of the identical fundus location. Nonetheless, they are as close to the same fundus location as possible. At the 10-year follow-up visit some progression of the inner retinal degeneration is seen. A few small cystic spaces are seen under the inner limiting membrane at baseline, and they appear larger and more numerous at the 10-year visit. While some retinal layers can be identified thoughout most of the lesion in the baseline scan, the 10-year scan reveals an almost complete loss of retinal organization within the torpedo lesion (E)Standard automated perimetry reveals a dense scotoma nasal to fixation that corresponds to the torpedo lesion in the temporal macula

The patient returned for follow-up in 2017 (Fig. 2, YEAR 5) and again in 2023 (Fig. 2, YEAR 10). Because the patient had relocated, her 2017 examination was conducted at the Southern California College of Optometry and her 2023 exam was conducted at the Medical College of South Carolina eye clinic. No changes in visual function were noted at either follow-up visit. Compared to her 2012 examination, OCT performed in 2023 revealed evidence of cystic degeneration of the neurosensory retina within the torpedo lesion. At the time of her 2023 exam she reported that she had discontinued Plaquenil in 2018 and her lupus was well controlled using belimumab. She denied a personal or family history of supernumerary teeth, cranial osteomas, epidermal cysts, intestinal polyposis, or brain and other tumors. The patient declined genetic testing of the APC gene. The patient has not undergone colonoscopy and her blood relatives were not available for examination. The patient was advised to self-monitor her vision with an Amsler grid.

Discussion

TM is likely a congenital lesion that results from a developmental defect of the eye. The youngest reported case is from an otherwise healthy and normal 6-month old child [16]. Yet, questions remain regarding the stability of the condition. Wong and colleagues proposed a TM classification scheme based upon lesion morphology [13]. They found that among the 5 patients in their case series and the 9 previously reported patients with OCT findings, patients that had TM associated with outer retinal cavitation (so-called Type 2 lesions) were on average older than patients having TM lesions without outer retinal cavitation (Type 1 lesions) − 17 years of age versus 39 years of age, respectively. They postulated that this is evidence of lesion progression, with outer retinal cavitation appearing as a later, more advanced form of the condition. However, Shirley and associates have reported on a case series of 7 children under 16 years of age with TM and OCT findings seen at their institution and found that patients with outer retinal cavitation were not on average older than children without outer retinal cavitation (7 and 8 years of age, respectively) [12].

Relatively few longitudinal studies of TM have been published, so the question of whether TM is a stable or progressive condition remains unresolved. Our review of the literature revealed 24 cases (including the current report) with greater than 1 year of follow-up (Table 1). Four of these 24 cases (17%) demonstrated some change in the torpedo lesion over the observation period. All four of the patients with documented change had 5 or more years of follow-up. Among all 7 cases with 5 or more years of follow-up, 57% (4 of 7 cases) demonstrated some change in lesion morphology. Reported changes consist of lesion enlargement and degeneration of retinal tissue within the torpedo lesion. Of the two cases presented herein, one patient had OCT evidence of degeneration of retinal tissue over the 10 year observation period while no changes were detected in the other patient. Baseline OCT scan of our Case 2 revealed a small number of hyporeflective cavities within the inner retina located predominantly in the temporal aspect of the torpedo lesion. The cystoid changes were poorly visualized at the 5 year exam but at the 10 year exam they had clearly become larger and more numerous. While fluorescein angiography was not performed, there is no OCT evidence of an exudative process, hence these lesions are likely of non-vasogenic origin, possibly secondary to mechanical/tractional stress induced by the excavation [17]. Of the 4 reported cases of lesion progression none has suffered any impairment of visual acuity as a consequence of lesion progression.

Table 1 Reported cases of torpedo maculopathy with greater than 1 year of follow-up

Vision loss secondary to TM

While TM is generally considered an asymptomatic and benign condition, vision loss may occur either because the torpedo lesion involves the fovea or secondary to complications arising from the torpedo lesion, such as choroidal neovascularization.

In addition to Case 2 reported herein, there are few other reported cases of torpedo lesions that involve the fovea. Makino and Tampo report on an unusual case of TM in the right eye of an 8 year old boy [18]. The torpedo lesion in the temporal macula had a satellite lesion superior to the main lesion and together they distorted the macula resulting in 0.03 (20/666) visual acuity. OCT through the lesion revealed inner retinal hyper-reflectivity with reduced thickness and disruption of the photoreceptor and retinal pigment epithelium layers. Giannakaki-Zimmermann, et al. reported on a patient with a fovea-involving torpedo lesion in the right eye resulting in 20/50 visual acuity [19]. They found that the torpedo lesion caused focal loss of the ellipsoid zone and interdigitation zone within the foveola. Light and Liu reported on a patient with a multi-partite torpedo lesion that was centered on the fovea of the left eye and resulted in a visual acuity of 20/40 [6]. OCT scan through the fovea of this eye also showed loss of the ellipsoid zone. Thus, if the torpedo lesion involves the fovea the patient’s visual acuity will be reduced.

The most frequently reported vision-threatening complication of TM is choroidal neovascularization. This appears to be a relatively uncommon complication, as our review of the literature revealed only 8 reported cases [4, 12, 20,21,22,23,24,25]. In six of the 8 cases (75%), the involved torpedo lesions contained a choroidal excavation. Because choroidal excavation is known to be associated with choroidal neovascularization [26], the presence of CNV in these eyes may be a consequence of choroidal excavation rather than a complication of TM itself. However, it is interesting to note that the 2 reported cases of CNV occurring in torpedo lesions without choroidal excavation are the youngest patients reported with this complication. The mean age of the two reported cases of CNV affecting torpedo lesions without choroidal excavation is 14.5 years compared to a mean age of 41 years for the 6 cases with choroidal excavation.

Differential diagnosis

Because the diagnosis of TM is made based on the clinical features of the condition, it is necessary to consider a variety of other retinal lesions that may share some features with TM before a diagnosis can be made. Conditions included in the differential diagnosis of TM are chorioretinal scar, congenital hypertrophy of the RPE, Gardner syndrome [27], and other syndromes associated with torpedo-like retinal lesions (such as Turcot syndrome [28], congenital Zika virus infection [29], and enhanced S-cone syndrome [30]).

Gardner syndrome is a variant of Familial Adenomatous Polyposis (FAP) where the retinal or other extraintestinal features are especially prominent. FAP is a condition caused by germline mutations in the adenomatous polyposis coli (APC) gene resulting in the development of hundreds to thousands of colorectal adenomas [31]. Left untreated approximately 100% of individuals with FAP will develop colorectal cancer. Approximately 70–80% of patients with FAP have pigmented retinal lesions, some of which have a torpedo-like shape [32].

It has recently been suggested that because Gardner syndrome and TM share numerous clinical features that they may share a common genetic etiology and pathogenesis [15]. Packo and Goldberg point out that the size, shape, variable pigmentation, adjacent depigmented halos and pigmented borders, presence of a tail, localized scotomas and subjacent choroidal excavation that characterize torpedo lesions in TM are all similar to the torpedo-like lesions of Gardner syndrome. Because of the pleiotropism and variable expressivity of Gardner syndrome, it is possible that TM represents a subclinical form of the systemic disorder. Therefore, Packo and Goldberg recommend that patients with TM (1) undergo evaluations for mutations in the APC gene, (2) undergo colonoscopy for intestinal polyps, and (3) individuals genetically related to patients with TM undergo inspection of their fundi for lesions characteristic of Gardner syndrome.

The clinical abnormalities associated with Gardner syndrome include supernumerary teeth, cranial osteomas, epidermal cysts, intestinal polyposis, brain and other tumors, and pigmented ocular fundus lesions [15]. Because our Case 1 reported a history of supernumerary teeth, we recommended genetic testing of the APC gene. Full gene sequencing with deletion and duplication analysis was undertaken. No pathogenic mutations, variants of unknown significance, or gross deletions or duplications were detected in the APC gene. Furthermore, a colonoscopy was ordered, and its results were normal. While we were unable to examine family members ourselves, we were informed that they all had normal eye examinations. Genetic testing was offered to Case 2 but it was declined.

Strengths of this case series are multimodal assessment of two patients with torpedo lesions at 5 and 10 years from baseline, which is, to our knowledge, the longest reported follow-up of the condition to date. Gene sequence and deletion/duplication analysis of the APC gene was performed on one patient with TM, which to our knowledge has not been previously reported. Limitations include examinations performed by various clinicians at multiple sites using differing instruments over the follow-up period which may adversely affect the ability to detect change.

Conclusion

We report on the long-term follow-up of two cases of TM. We found no clinically significant progression of the disorder over a 10 year observation period. Lesion morphology and visual function remained largely stable in both patients, with only minor degenerative changes observed in one case. Furthermore, genetic testing and colonoscopy of one of our patients found no evidence of Gardner syndrome. Our findings support the position that TM is an essentially stable, nonprogressive disorder. While we could find no evidence of Gardner syndrome in our patient, we endorse the recommendation that individuals with TM and possible manifestations of Gardner syndrome should undergo investigations to rule out the condition.

Availability of data and materials

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

  1. Menezes K, Mancera N, Patel H, Kattih Z, Mhaskar R. Torpedo maculopathy: a systematic review of case reports. Ophthalmic Surg Lasers Imaging Retina. 2021;52:78–83.

    Article  PubMed  Google Scholar 

  2. Williams PJ, Salek S, Prinzi RA, Bergstrom C, Hubbard GB. Distribution patterns of torpedo maculopathy: further evidence of a congenital retinal nerve fiber layer-driven etiology. Saudi J Ophthalmol. 2019;33:260–7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Shields CL, Guzman JM, Shapiro MJ, Fogel LE, Shields JA. Torpedo maculopathy at the site of the fetal bulge. Arch Ophthalmol. 2010;128:499–501.

    Article  PubMed  Google Scholar 

  4. Parodi MB, Romano F, Montagna M, Albertini GC, Pierro L, Arrigo A, Bandello F. Choroidal neovascularization in torpedo maculopathy assessed on optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retina. 2018;49:E210–3.

    Article  PubMed  Google Scholar 

  5. Dolz-Marco R, Saffra NA, Freund KB. Torpedo Maculopathy presenting with a Vitelliform Lesion. Retina. 2017;37:e19–20.

    Article  PubMed  Google Scholar 

  6. Light JG, Liu TYA. A novel phenotype of torpedo maculopathy on spectral-domain optical coherence tomography. Am J Ophthalmol Case Rep. 2020;20:100956.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Richez F, Gueudry J, Brasseur G, Muraine M. [Bilateral torpedo maculopathy]. J Fr Ophthalmol. 2010;33:296.

    Article  CAS  Google Scholar 

  8. Rohl A, Vance S. Hyperpigmented Torpedo Maculopathy with Pseudo-lacuna: a 5-Year Follow-Up. Case Rep Ophthalmol. 2016;7:184–90.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Smith MJ, Sia DIT, Greve M. Torpedo maculopathy - inferior variant. Can J Ophthalmol. 2021;S0008–4182:00045–4.

    Google Scholar 

  10. Kerwat D, Jamall O, Antonakis S, Almeida GC. Torpedo maculopathy: a case series – insights into basic pathology. Eur J Ophthalmol. 2021;31:NP35–9.

    Article  PubMed  Google Scholar 

  11. Sanabria MR, Coco RM, Sanchidrian M. OCT findings in Torpedo Maculopathy. Retin Cases Brief Rep. 2008;2:109–11.

    Article  PubMed  Google Scholar 

  12. Shirley K, O’Neill M, Gamble R, Ramsey A, McLoone E. Torpedo maculopathy: Disease spectrum and associated choroidal neovascularisation in a paediatric population. Eye Lond. 2018;32:1315–20.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wong EN, Fraser-Bell S, Hunyor AP, Chen FK. Novel optical coherence tomography classification of torpedo maculopathy. Clin Exp Ophthalmol. 2015;43:342–8.

    Article  PubMed  Google Scholar 

  14. Trevino R, Kiani S, Raveendranathan P. The expanding clinical spectrum of torpedo maculopathy. Optom Vis Sci. 2014;91:71–8.

    Article  Google Scholar 

  15. Packo K, Goldberg MF. Torpedo-like lesions in the ocular fundi of Gardner syndrome: hiding in plain view. Ophthalmic Genet. 2021;42:514–20.

    Article  PubMed  Google Scholar 

  16. Kara C, Petriçli IS. Torpedo Maculopathy in a 6-Month-Old infant: early clinical and optical coherence tomography findings. J Pediatr Ophthalmol Strabismus. 2017;54:e54–7.

    Article  PubMed  Google Scholar 

  17. Gaudric A, Audo I, Vignal C, Couturier A, Boulanger-Scemama É, Tadayoni R, Cohen SY. Non-vasogenic cystoid maculopathies. Prog Retin Eye Res. 2022;91:101092.

    Article  PubMed  CAS  Google Scholar 

  18. Makino S, Tampo H. Unusual torpedo maculopathy. JSM Ophthalmol. 2014;2:1017.

    Google Scholar 

  19. Giannakaki-Zimmermann H, Munk MR, Dysli C, Ebneter A, Wolf S, Zinkernagel MS. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF TORPEDO MACULOPATHY. Retin Cases Brief Rep. 2019;13:337–42.

    Article  PubMed  Google Scholar 

  20. Banaee T, Doss M, Eller AW. Torpedo maculopathy complicated by choroidal neovascularization. Am J Ophthalmol Case Rep. 2020;19:100772–2.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Byer M, Rousso L, Rodman J, Shechtman D. Case Report: Use of Multimodal Imaging to Document a Rare complication of Torpedo Maculopathy. Optom Vis Sci. 2021;98:870–5.

    Article  PubMed  Google Scholar 

  22. Ghezzaz A, Idlefqih W, Chahed S, Mahdjoubi A, CHOROIDAL NEOVASCULARIZATION IN, TORPEDO MACULOPATHY TREATED BY AFLIBERCEPT: LONG-TERM FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retin Cases Brief Rep. 2023;17:433–7.

    Article  PubMed  Google Scholar 

  23. Jurjevic D, Böni C, Barthelmes D, Fasler K, Becker M, Michels S, Stemmle J, Herbort C, Zweifel SA. Torpedo Maculopathy Associated with Choroidal Neovascularization. Klin Monbl Augenheilkd. 2017;234:508–14.

    Article  PubMed  CAS  Google Scholar 

  24. Soman M, Indurkar A, Mohan A, Nair U. Secondary choroidal neovascular membrane in a case of torpedo maculopathy. Indian J Ophthalmol. 2020;68:2499–500.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Venkatesh R, Jain K, Pereira A, Thirumalesh MB, Yadav NK. Torpedo Retinopathy. J Ophthalmic Vis Res. 2020;15:187–94.

    PubMed  PubMed Central  Google Scholar 

  26. Inanc M, Tekin K, Teke M, Kiziltoprak H. Tomographic characteristics of focal choroidal excavation and its association with retinal disorders. Eur J Ophthalmol. 2021;31:1154–60.

    Article  PubMed  Google Scholar 

  27. Villegas VM, Schwartz SG, Flynn HW, Capó H, Berrocal AM, Murray TG, Harbour JW. Distinguishing torpedo maculopathy from similar lesions of the posterior segment. Ophthalmic Surg Lasers Imaging Retina. 2014;45:222–6.

    Article  PubMed  Google Scholar 

  28. Mokhashi N, Cai LZ, Shields CL, Benson WE, Ho AC. Systemic considerations with pigmented fundus lesions and retinal pigment epithelium hamartomas in Turcot syndrome. Curr Opin Ophthalmol. 2021;32:567–73.

    Article  PubMed  Google Scholar 

  29. de Miranda HA, Costa MC, Frazão MAM, Simão N, Franchischini S, Moshfeghi DM. Expanded spectrum of congenital ocular findings in Microcephaly with presumed Zika Infection. Ophthalmology. 2016;123:1788–94.

    Article  PubMed  Google Scholar 

  30. Yzer S, Barbazetto I, Allikmets R, van Schooneveld MJ, Bergen A, Tsang SH, Jacobson SG, Yannuzzi LA. Expanded clinical spectrum of enhanced S-cone syndrome. JAMA Ophthalmol. 2013;131:1324–30.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis. 2009;4:22.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Traboulsi EI, Krush AJ, Gardner EJ, Booker SV, Offerhaus GJ, Yardley JH, Hamilton SR, Luk GD, Giardiello FM, Welsh SB. Prevalence and importance of pigmented ocular fundus lesions in Gardner’s syndrome. N Engl J Med. 1987;316:661–7.

    Article  PubMed  CAS  Google Scholar 

  33. Hansen MS, Larsen M, Hove MN. Optical coherence tomography of torpedo maculopathy in a patient with tuberous sclerosis. Acta Ophthalmol. 2016;94:736–7.

    Article  PubMed  Google Scholar 

  34. Pian D, Ferrucci S, Anderson SF, Wu C. Paramacular coloboma. Optom Vis Sci. 2003;80:556–63.

    Article  PubMed  Google Scholar 

  35. Golchet PR, Jampol LM, Mathura JR, Daily MJ. Torpedo maculopathy. Br J Ophthalmol. 2010;94:302–6.

    Article  PubMed  Google Scholar 

  36. Dutra-Medeiros M, Leitão P, Magriço A, Toscano A. Torpedo maculopathy with an anisometropic amblyopia in a 5-year-old caucasian girl: case report. Arq Bras Oftalmol. 2013;76:253–5.

    Article  PubMed  Google Scholar 

  37. Schuerch K, Ebneter A, Zinkernagel M. Two case reports of torpedo maculopathy. Klin Monbl Augenheilkd. 2015;232:558–9.

    Article  PubMed  CAS  Google Scholar 

  38. de Manuel-Triantafilo S, Gili P, Bañuelos Bañuelos J. Torpedo maculopathy: two case reports and a literature review. Arch Soc Espanola Oftalmol. 2016;91:400–3.

    Google Scholar 

  39. Suárez AR, Moreno SG, Moreno EB, Capote AC, Soto ML, Martín FG. Autofluorescence and optical coherence tomography in torpedo maculopathy: a case report. Rev Mex Oftalmol. 2017;91:99–102.

    Google Scholar 

  40. Ehrenberg M, Gal Or O, Friling R, Pesoa Y, Dotan G, Sternfeld A. Incidental unilateral Macular Lesions in Children. Ophthalmic Surg Lasers Imaging Retina. 2023;54:346–52.

    Article  PubMed  Google Scholar 

  41. Ding Y, Yao B, Ye H, Yu Y. Multimodal imaging of torpedo maculopathy in a Chinese woman: a case report. BMC Ophthalmol. 2019;19:154.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Drs Salma Kiani, Praneetha Raveendranathan and Mariah Marshall participated in the care of case 1.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

All authors (RCT, WHR, AL, JH) have made substantive intellectual contributions to this manuscript. RCT wrote the main manuscript text. All authors examined the patients and participated in their care. RCT obtained consent of the patients. RCT and WHR revised the manuscript. RCT prepared the figures. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Richard C. Trevino.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Informed consent was obtained from the patients for publication of the details of their medical case and accompanying images. No identifiable health information was included in this case report.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trevino, R.C., Ridder, W.H., Laul, A. et al. Long-term follow-up of torpedo maculopathy: a case series and mini-review. BMC Ophthalmol 24, 5 (2024). https://doi.org/10.1186/s12886-023-03254-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12886-023-03254-z

Keywords